Options
Cost-effective Treatment with Half Year of Trastuzumab and Chemotherapy as Adjuvant Treatment for Over Expression of Her2/Neu Breast Cancer Patients: Two Institutional Experiences in Taiwan
Type
conference
Resource
2006 American Society of Clinical Oncology(ASCO), Atlanta, U.S.A.
Date Issued
2006
Author(s)
戴承正
Cheng-Jeng Tai; Chin-Kwun Pan; Chi-Hsiung Wu; Ching-Syiang Chen
Subjects
內科學科
會議論文